Inverness Counsel’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,035
| Closed | -$212K | – | 195 |
|
|
2021
Q3 | $212K | Buy |
+3,035
| New | +$212K | 0.01% | 169 |
|
|
2020
Q3 | – | Sell |
-2,716
| Closed | -$209K | – | 138 |
|
|
2020
Q2 | $209K | Buy |
+2,716
| New | +$209K | 0.01% | 117 |
|
|
2017
Q2 | – | Sell |
-3,204
| Closed | -$212K | – | 94 |
|
|
2017
Q1 | $212K | Sell |
3,204
-2,705
| -46% | -$179K | 0.01% | 88 |
|
|
2016
Q4 | $430K | Sell |
5,909
-35,030
| -86% | -$2.55M | 0.03% | 77 |
|
|
2016
Q3 | $3.24M | Sell |
40,939
-87,759
| -68% | -$6.94M | 0.25% | 49 |
|
|
2016
Q2 | $10.7M | Sell |
128,698
-180,330
| -58% | -$15M | 0.83% | 39 |
|
|
2016
Q1 | $28.4M | Buy |
309,028
+3,407
| +1% | +$313K | 2.2% | 16 |
|
|
2015
Q4 | $30.9M | Buy |
305,621
+16,570
| +6% | +$1.68M | 2.34% | 12 |
|
|
2015
Q3 | $28.4M | Buy |
289,051
+58,373
| +25% | +$5.73M | 2.4% | 10 |
|
|
2015
Q2 | $27M | Sell |
230,678
-11,170
| -5% | -$1.31M | 1.96% | 16 |
|
|
2015
Q1 | $23.7M | Sell |
241,848
-41,770
| -15% | -$4.1M | 1.75% | 21 |
|
|
2014
Q4 | $26.7M | Sell |
283,618
-70,056
| -20% | -$6.6M | 2.05% | 16 |
|
|
2014
Q3 | $37.6M | Sell |
353,674
-46,956
| -12% | -$5M | 3.02% | 5 |
|
|
2014
Q2 | $33.2M | Sell |
400,630
-74,641
| -16% | -$6.19M | 2.59% | 8 |
|
|
2014
Q1 | $33.7M | Sell |
475,271
-170,340
| -26% | -$12.1M | 2.68% | 6 |
|
|
2013
Q4 | $48.5M | Sell |
645,611
-14,204
| -2% | -$1.07M | 3.85% | 4 |
|
|
2013
Q3 | $41.5M | Sell |
659,815
-29,773
| -4% | -$1.87M | 3.56% | 4 |
|
|
2013
Q2 | $35.4M | Buy |
+689,588
| New | +$35.4M | 3.15% | 4 |
|